These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11405213)

  • 1. X chromosome inactivation ratios in female carriers of X-linked sideroblastic anemia.
    Aivado M; Gattermann N; Bottomley S
    Blood; 2001 Jun; 97(12):4000-2. PubMed ID: 11405213
    [No Abstract]   [Full Text] [Related]  

  • 2. Familial-skewed X-chromosome inactivation as a predisposing factor for late-onset X-linked sideroblastic anemia in carrier females.
    Cazzola M; May A; Bergamaschi G; Cerani P; Rosti V; Bishop DF
    Blood; 2000 Dec; 96(13):4363-5. PubMed ID: 11110715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sideroblastic anemia segregating with glucose-6-phosphate dehydrogenase deficiency.
    Brewer GJ
    Am J Hematol; 1992 Apr; 39(4):307-8. PubMed ID: 1553960
    [No Abstract]   [Full Text] [Related]  

  • 4. Molecular genetics of "X-linked" sideroblastic anemia.
    Mantzourani M; Konstantopoulos K; Voskaridou E; Loukopoulos D
    Am J Hematol; 1995 Feb; 48(2):131. PubMed ID: 7847329
    [No Abstract]   [Full Text] [Related]  

  • 5. Pyridoxine-refractory congenital sideroblastic anaemia with evidence for autosomal inheritance: exclusion of linkage to ALAS2 at Xp11.21 by polymorphism analysis.
    Jardine PE; Cotter PD; Johnson SA; Fitzsimons EJ; Tyfield L; Lunt PW; Bishop DF
    J Med Genet; 1994 Mar; 31(3):213-8. PubMed ID: 7912287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. X-linked sideroblastic anemia and ataxia: linkage to phosphoglycerate kinase at Xq13.
    Raskind WH; Wijsman E; Pagon RA; Cox TC; Bawden MJ; May BK; Bird TD
    Am J Hum Genet; 1991 Feb; 48(2):335-41. PubMed ID: 1671320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concise review: genetic bases for sideroblastic anemia.
    Nusbaum NJ
    Am J Hematol; 1991 May; 37(1):41-4. PubMed ID: 2024639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a highly polymorphic marker within intron 7 of the ALAS2 gene and suggestion of at least two loci for X-linked sideroblastic anemia.
    Cox TC; Kozman HM; Raskind WH; May BK; Mulley JC
    Hum Mol Genet; 1992 Nov; 1(8):639-41. PubMed ID: 1301172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linkage analysis of a large pedigree with hereditary sideroblastic anaemia.
    Noble JS; Taylor GR; Losowsky MS; Hall R; Turner G; Mueller RF; Stewart AD
    J Med Genet; 1995 May; 32(5):389-92. PubMed ID: 7616548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A family study of congenital X linked sideroblastic anaemia.
    Holmes J; May A; Geddes D; Jacobs A
    J Med Genet; 1990 Jan; 27(1):26-8. PubMed ID: 2308152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Onset of X-linked sideroblastic anemia in the fourth decade.
    Cortesão E; Vidan J; Pereira J; Gonçalves P; Ribeiro ML; Tamagnini G
    Haematologica; 2004 Oct; 89(10):1261-3. PubMed ID: 15477213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythroid 5-aminolevulinate synthase and X-linked sideroblastic anemia.
    Ferreira GC
    J Fla Med Assoc; 1993 Jul; 80(7):481-3. PubMed ID: 8089650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new mutation of the ALAS2 gene in a large family with X-linked sideroblastic anemia.
    Prades E; Chambon C; Dailey TA; Dailey HA; Brière J; Grandchamp B
    Hum Genet; 1995 Apr; 95(4):424-8. PubMed ID: 7705839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [X-linked sideroblastic anemia].
    Muramatsu M; Usuki K; Izutsu K; Yamaguchi Y; Iki S; Furuyama K; Kondo M; Urabe A
    Rinsho Ketsueki; 1999 Jul; 40(7):593-8. PubMed ID: 10483144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. X-linked, pyridoxine-responsive sideroblastic anemia.
    Harris JW
    N Engl J Med; 1994 Mar; 330(10):709-11. PubMed ID: 8107723
    [No Abstract]   [Full Text] [Related]  

  • 16. Molecular defects of erythroid 5-aminolevulinate synthase in X-linked sideroblastic anemia.
    Bottomley SS; May BK; Cox TC; Cotter PD; Bishop DF
    J Bioenerg Biomembr; 1995 Apr; 27(2):161-8. PubMed ID: 7592563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maximum-likelihood analysis of human T-cell X chromosome inactivation patterns: normal women versus carriers of X-linked severe combined immunodeficiency.
    Puck JM; Stewart CC; Nussbaum RL
    Am J Hum Genet; 1992 Apr; 50(4):742-8. PubMed ID: 1550118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. X-linked sideroblastic anemia associated with a novel ALAS2 mutation and unfortunate skewed X-chromosome inactivation patterns.
    Aivado M; Gattermann N; Rong A; Giagounidis AA; Prall WC; Czibere A; Hildebrandt B; Haas R; Bottomley SS
    Blood Cells Mol Dis; 2006; 37(1):40-5. PubMed ID: 16735131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel mutation in exon 5 of the ALAS2 gene results in X-linked sideroblastic anemia.
    Hurford MT; Marshall-Taylor C; Vicki SL; Zhou JZ; Silverman LM; Rezuke WN; Altman A; Tsongalis GJ
    Clin Chim Acta; 2002 Jul; 321(1-2):49-53. PubMed ID: 12031592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late-onset X-linked sideroblastic anemia. Missense mutations in the erythroid delta-aminolevulinate synthase (ALAS2) gene in two pyridoxine-responsive patients initially diagnosed with acquired refractory anemia and ringed sideroblasts.
    Cotter PD; May A; Fitzsimons EJ; Houston T; Woodcock BE; al-Sabah AI; Wong L; Bishop DF
    J Clin Invest; 1995 Oct; 96(4):2090-6. PubMed ID: 7560104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.